Letter to the Shareholders

To our Shareholders

On behalf of the board (the “Board”) of directors (the “Director”) of Perfect Medical Health Management Limited (the “Company”), together with its subsidiaries (collectively, the “Group”), I am pleased to present the annual results of the Group for the financial year ended 31 March 2026 (the “Year”).

RESILIENT PERFORMANCE AND STRATEGIC FOCUS

The Group began the Year facing a complex operating environment, marked by cautious consumer sentiment and shifting spending patterns, including increased outbound travel. Despite these headwinds, the Group maintained operational discipline and executed timely adjustments to its business model. These included strategic consolidation of the store network and rigorous cost management. As market conditions improved in the second half of the Year, the Group delivered a solid operational recovery, supported by stronger customer demand and improved operating efficiency.

This recovery was underpinned by the Group’s continued focus on premium service offerings, operational agility, and a disciplined approach to network optimization. The combination of these factors helped narrow the full-year decline in profitability and positioned the Group on a more stable footing as it enters the new financial year.

STRENGTHENING OUR COMPETITIVE POSITION

In an increasingly competitive landscape, the Group has prioritized sustainable differentiation over short-term volume growth. Rather than engaging in price competition, we have focused on reinforcing brand equity through premiumization, enhancing customer experience, and optimizing operational leverage. This approach has helped protect margins while strengthening our market position in both Hong Kong and Mainland China.

ADVANCING OUR MULTI-BRAND STRATEGY AND DIGITAL CAPABILITIES

A key element of our long-term growth strategy is the development of a diversified multi-brand ecosystem. During the Year, the Group entered into an exclusive cooperation agreement with “Oracle”, a leading Korean medical beauty brand, for the Hong Kong market. The initial rollout has been well received and has successfully broadened our customer base to include a younger demographic.

At the same time, the Group has accelerated its digital transformation by integrating artificial intelligence across marketing, customer relationship management, and operational processes. These initiatives are expected to improve marketing efficiency, enhance customer retention, and support more scalable operations over time.

FINANCIAL DISCIPLINE AND SHAREHOLDER RETURNS

The Group has consistently maintained a prudent financial policy. We ended the Year with a healthy, debt-free balance sheet and strong operating cash flows. In line with our long-standing commitment to shareholders, the Board has proposed a final dividend of HK7.0 cents per share. Together with the interim dividend of HK7.6 cents per share, the total dividend for the Year represents a payout ratio of 100% or above for the eleventh consecutive year. This reflects both our financial strength and our confidence in the Group’s sustainable earnings capacity.

OUTLOOK

Looking ahead to the financial year ending 31 March 2027, the Group will continue to build on the operational improvements achieved during the Year. While the external environment is expected to remain dynamic, we are well positioned to pursue measured growth.

Our priorities include further strengthening our core services in Hong Kong, selectively expanding our multi-brand portfolio, and exploring strategic opportunities that align with long-term value creation. We will maintain our disciplined approach to cost management and capital allocation while leveraging our optimized network and digital capabilities to capture opportunities as consumer confidence continues to recover.

APPRECIATION

On behalf of the Board, I would like to express my sincere appreciation to our management team and all staff members for their dedication and hard work throughout the Year. Their commitment was instrumental in delivering the Group’s recovery.

I would also like to thank our shareholders, customers, and business partners for their continued trust and support. We remain focused on delivering sustainable, long-term value and look forward to sharing further progress in the year ahead.

Dr. Au Yeung Kong

Chairman

Hong Kong, 30 June 2026

Hong Kong No.1 Doctor-Founded Multi-national Healthcare and Medical Beauty Group

Founded by Doctor

Continuously Annual Dividend Growth

Constituent Stock of the MSCI Hong Kong Micro Cap Index

COPYRIGHT © PERFECT MEDICAL BEAUTY GROUP LIMITED 2026. ALL RIGHTS RESERVED.